Edition:
United States

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

111.65USD
18 Dec 2018
Change (% chg)

$0.89 (+0.80%)
Prev Close
$110.76
Open
$111.79
Day's High
$112.23
Day's Low
$110.48
Volume
258,626
Avg. Vol
201,110
52-wk High
$116.61
52-wk Low
$84.67

Latest Key Developments (Source: Significant Developments)

ResMed To Acquire MatrixCare For $750 Mln
Monday, 5 Nov 2018 09:05am EST 

Nov 5 (Reuters) - ResMed Inc ::RESMED TO ACQUIRE MATRIXCARE, EXPANDS OUT-OF-HOSPITAL SAAS PORTFOLIO INTO LONG-TERM CARE SETTINGS.RESMED INC - PURCHASE PRICE $750 MILLION, ACCRETIVE TO NON-GAAP GROSS MARGIN AND NON-GAAP DILUTED EARNINGS PER SHARE.RESMED INC - RESMED WILL ACQUIRE MATRIXCARE FOR $750 MILLION, WHICH RESMED WILL FUND PRIMARILY WITH ITS CREDIT FACILITY.RESMED INC - IN CALENDAR YEAR 2018, MATRIXCARE PRO FORMA NET REVENUE IS ESTIMATED TO BE APPROXIMATELY $122 MILLION.RESMED INC - MATRIXCARE WILL CONTINUE TO OPERATE AS A STANDALONE BUSINESS WITHIN RESMED'S SAAS PORTFOLIO.RESMED INC - FOLLOWING COMPLETION OF TRANSACTION, CO INTENDS TO SUSPEND ITS SHARE REPURCHASE PROGRAM.RESMED INC - MATRIXCARE CEO JOHN DAMGAARD WILL CONTINUE IN HIS CURRENT ROLE, REPORTING TO RAJ SODHI.RESMED INC - ON COMPLETION OF TRANSACTION, MATRIXCARE WILL CONTINUE TO OPERATE AS A STANDALONE BUSINESS WITHIN RESMED'S SAAS PORTFOLIO.RESMED INC - THERE WILL BE NO IMMEDIATE CHANGES TO MATRIXCARE MANAGEMENT, LOCATIONS OR BUSINESS PROCESSES.  Full Article

Fisher & Paykel Healthcare Says Co Filed Complaint With U.S. International Trade Commission
Monday, 10 Sep 2018 05:28pm EDT 

Sept 11 (Reuters) - Fisher & Paykel Healthcare Corporation Ltd ::HAS FILED A COMPLAINT WITH US INTERNATIONAL TRADE COMMISSION.ADVISES THAT EARNINGS GUIDANCE FOR FY19, REMAINS UNCHANGED .SEEKING EXCLUSION ORDER TO PREVENT IMPORTATION AND SALE OF RESMED'S AIRFIT P10 RANGE OF NASAL PILLOWS MASKS IN U.S.  Full Article

Resmed Files Patent Infringement Action Against Fisher & Paykel
Friday, 31 Aug 2018 04:05pm EDT 

Aug 31 (Reuters) - Resmed Inc ::RESMED FILES PATENT INFRINGEMENT ACTION AGAINST FISHER & PAYKEL.RESMED INC - RESMED FILES NEW INFRINGEMENT ACTION AGAINST FISHER & PAYKEL'S SIMPLUS, ESON AND ESON 2 MASKS.  Full Article

Gemco Medical Says Announces Partnership With Brightree
Wednesday, 7 Feb 2018 11:36am EST 

Feb 7 (Reuters) - GEMCO MEDICAL ::GEMCO MEDICAL, A DISTRIBUTOR FOR MEDICAL SUPPLY PROVIDERS, SAYS ANNOUNCES ITS PARTNERSHIP WITH BRIGHTREE.GEMCO MEDICAL SAYS BRIGHTREE PARTNERSHIP ALLOWS DME/HME DEALERS TO PLACE GEMCO ORDERS DIRECTLY FROM BRIGHTREE INTEGRATED EPURCHASING PLATFORM.  Full Article

ResMed Q2 Gaap Earnings Per Share $0.07
Monday, 22 Jan 2018 04:05pm EST 

Jan 22 (Reuters) - ResMed Inc ::ANNOUNCES RESULTS FOR THE SECOND QUARTER OF FISCAL YEAR 2018.Q2 GAAP EARNINGS PER SHARE $0.07.Q2 REVENUE $601.3 MILLION VERSUS I/B/E/S VIEW $579.7 MILLION.Q2 EARNINGS PER SHARE VIEW $0.77 -- THOMSON REUTERS I/B/E/S.Q2 NON-GAAP EARNINGS PER SHARE $1.00.  Full Article

Fisher & Paykel Healthcare Corporation ‍says wins patent case against ResMed in UK court​
Sunday, 12 Nov 2017 03:23pm EST 

Nov 13 (Reuters) - Fisher & Paykel Healthcare Corporation Ltd :‍Wins patent case against ResMed in UK court.Patent found invalid, ‍subject to appeal, European patent will be revoked in UK​.  Full Article

Resmed Inc reports Q1 earnings $0.60/shr
Thursday, 26 Oct 2017 04:05pm EDT 

Oct 26 (Reuters) - Resmed Inc :Resmed Inc. Announces results for the first quarter of fiscal year 2018.Q1 GAAP earnings per share $0.60.Q1 revenue $523.7 million versus I/B/E/S view $505.6 million.Q1 earnings per share view $0.66 -- Thomson Reuters I/B/E/S.  Full Article

Fisher & Paykel Healthcare says German court suspends patent proceedings against co
Thursday, 28 Sep 2017 04:23pm EDT 

Sept 29 (Reuters) - Fisher & Paykel Healthcare Corporation Ltd :German court suspends patent proceedings against FPH.Successful in having two patent proceedings brought by Resmed against co's entities in regional court in Munich suspended​.Court ruled cases relating to Resmed's assertion of patents be suspended pending outcome of oppositions filed by co.  Full Article

Resmed Q4 GAAP earnings per share $0.71
Tuesday, 1 Aug 2017 04:05pm EDT 

Aug 1 (Reuters) - Resmed Inc :Resmed Inc. announces results for the fourth quarter of fiscal year 2017.Q4 GAAP earnings per share $0.71.Q4 revenue $556.7 million versus I/B/E/S view $555.7 million.Q4 earnings per share view $0.75 -- Thomson Reuters I/B/E/S.Resmed Inc says quarterly dividend increased by 6% to $0.35 per share.  Full Article

Resmed plans to renew its patent infringement case against Fisher & Paykel
Wednesday, 17 May 2017 03:58am EDT 

May 17 (Reuters) - Resmed Inc ::Statement by ResMed on plans to renew its patent infringement case against Fisher & Paykel.Filed motion to dismiss current ITC complaint so that it can refile, incorporate additional evidence generated since original complaint was filed.  Full Article

USITC to investigate Resmed for alleged patent infringement

WASHINGTON The U.S. International Trade Commission (USITC) said on Friday it would investigate California-based Resmed Inc for a patent infringement complaint related to sleep apnea mask systems.